Invention Grant
- Patent Title: TLR7/8 antagonists and uses thereof
-
Application No.: US16037368Application Date: 2018-07-17
-
Publication No.: US10793553B2Publication Date: 2020-10-06
- Inventor: Brian A. Sherer , Nadia Brugger , Ruoxi Lan , Xiaoling Chen
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Grüneberg and Myers PLLC
- Main IPC: C07D403/10
- IPC: C07D403/10 ; A61P9/10 ; A61P29/00 ; A61P19/02 ; A61P35/00 ; A61P3/10 ; C07D401/14 ; C07D401/10 ; A61P25/16 ; A61P17/06 ; C07D471/04 ; A61P25/28
Abstract:
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TLR7/8 antagonists.
Public/Granted literature
- US20190023687A1 TLR7/8 ANTAGONISTS AND USES THEREOF Public/Granted day:2019-01-24
Information query
